The US Food and Drug Administration and long-acting beta2-agonists: the importance of striking the right balance between risks and benefits of therapy? (Q42943544)
Jump to navigation
Jump to search
scientific article published on 7 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The US Food and Drug Administration and long-acting beta2-agonists: the importance of striking the right balance between risks and benefits of therapy? |
scientific article published on 7 August 2010 |
Statements
1 reference
The US Food and Drug Administration and long-acting beta2-agonists: the importance of striking the right balance between risks and benefits of therapy? (English)
1 reference
William W Busse
1 reference
Robert F Lemanske
1 reference
7 August 2010
1 reference
1 reference
Identifiers
1 reference